BrightSpring Health Services filings document the operating results, governance, capital structure and material events of a public home- and community-based healthcare services company. Its 8-K reports include quarterly financial results, preliminary financial information, completed asset dispositions, underwriting agreements, secondary common stock offerings, company share repurchases and related registration-statement disclosures.
The company’s proxy materials cover annual meeting matters, director and governance disclosures, executive compensation and shareholder voting topics. BrightSpring filings also identify its Nasdaq-listed common stock under BTSG and its 6.75% Tangible Equity Units under BTSGU, providing formal disclosure around both operating performance and security structure.
BrightSpring Health Services (BTSG) reported an insider equity transaction by its Chairman, President and CEO. On 10/25/2025, a Code F event reflected 49,796 shares of common stock withheld to cover taxes at $33.53, tied to the vesting of 109,442 RSUs (net settled at the 10/24/2025 close). After the transaction, the reporting person beneficially owns 1,082,134 shares directly and 369,763 shares indirectly through the Rousseau Family Trust.
BrightSpring Health Services (BTSG) reported strong Q3 2025 results. Total revenue rose to $3.334 billion from $2.601 billion a year ago, led by Products at $2.967 billion and Services at $367.1 million. Gross profit was $392.0 million and operating income increased to $87.8 million from $29.1 million.
Net income was $55.2 million versus a $9.0 million loss last year; diluted EPS was $0.26 compared with a $0.04 loss. Year-to-date operating cash flow reached $258.6 million. Cash and cash equivalents were $140.3 million, and long-term debt (net of current portion) was $2.465 billion.
The Community Living business is classified as discontinued operations and contributed $17.8 million of income in Q3. The company agreed to sell this business for $835.0 million in cash, with closing expected in the first fiscal quarter of 2026, subject to approvals. In October, selling stockholders completed a 15,000,000-share secondary offering; the company concurrently purchased 1,500,000 of those shares at the underwriter’s purchase price.
BrightSpring Health Services, Inc. furnished an 8-K to announce it issued a press release with financial results for the quarter ended September 30, 2025. The press release, dated October 28, 2025, is included as Exhibit 99.1.
The company states the information under Item 2.02, including Exhibit 99.1, is furnished and not deemed “filed” under Section 18 of the Exchange Act, and will only be incorporated by reference if expressly stated.
BrightSpring Health Services (BTSG): Insider Form 4 reports major shareholder transactions. Reporting persons affiliated with KKR disclosed the sale of 14,745,000 shares of common stock on 10/22/2025 in an underwritten public offering at a net price of $28.782 per share. Following the sale, beneficially owned shares were 62,351,337 on an indirect basis.
An additional entry reflects 409,305 shares classified under code J as in-kind distributions to partners and shareholders to facilitate charitable donations, leaving 61,942,032 shares beneficially owned indirectly. Separate bona fide gifts (code G) were reported for 50,484 shares by Mr. Kravis and 39,493 shares by Mr. Roberts. The filing notes indirect ownership through KKR Phoenix Aggregator L.P. and customary beneficial ownership disclaimers.
BrightSpring Health Services (BTSG) reported an insider transaction by its Chairman, President and CEO. On October 22, 2025, the reporting person exercised 235,000 stock options at $6.37 and sold 235,000 common shares at $28.782 pursuant to a registered public offering.
Following the transactions, direct ownership stands at 1,131,930 common shares. The filing also lists 369,763 shares held indirectly by the Rousseau Family Trust. Remaining option holdings include 560,241 options (direct) and indirect options of 534,676 (by The Margaret Rousseau Children Trust) and 377,602 (by the Rousseau Family Trust), each with a $6.37 exercise price and 10/16/2029 expiration. The options are noted as fully vested.
BrightSpring Health Services (BTSG) reported an insider transaction by its Chief of Staff and SVP, Human Resources. On October 22, 2025, the officer exercised 20,000 stock options at $6.37 per share and sold 20,000 common shares at $28.782 pursuant to a registered public offering that closed the same day.
Following these transactions, the officer directly beneficially owned 131,150 common shares. Derivative holdings listed included 71,578 stock options remaining beneficially owned. The filing notes the options are fully vested.
BrightSpring Health Services (BTSG) disclosed an underwritten secondary offering of 15,000,000 shares of common stock by selling stockholders, including KKR Phoenix Aggregator L.P., under an automatic shelf on Form S-3ASR. The closing of the offering and related share repurchase occurred on October 22, 2025.
The Company did not receive proceeds from the offering, other than cash received from Management Selling Stockholders’ stock option exercises in connection with the transaction. BrightSpring repurchased 1,500,000 shares from the underwriter as part of the offering, and the underwriter did not receive underwriting fees on the repurchased shares. The underwriting agreement includes customary representations, conditions, and indemnification provisions.
BrightSpring Health Services, Inc. is registering the resale of 15,000,000 shares of common stock by selling stockholders under a prospectus supplement filed pursuant to Rule 424(b)(7). The company will not receive proceeds from these sales, other than cash received from management stockholders’ option exercises made in connection with the offering.
The underwriter agreed to purchase at $28.7820 per share, resulting in total proceeds to selling stockholders of $431,730,000 before expenses. Subject to the offering’s completion, BrightSpring intends to concurrently repurchase 1,500,000 of these shares from the underwriter at the same price, fund the repurchase with cash on hand, and cancel the shares; the offering is not conditioned on the repurchase.
BTSG is listed on Nasdaq; the shares closed at $30.47 on October 20, 2025. Shares outstanding were 181,045,317 as of October 17, 2025; after the offering and repurchase, shares outstanding would be 179,800,317 after giving effect to 255,000 option exercises.
Preliminary Q3 2025 results (continuing ops): revenue $3,334 million (+28%), net income $37.5 million, and Adjusted EBITDA $160 million (+37%).
BrightSpring Health Services filed a resale prospectus for 15,000,000 shares of common stock offered by selling stockholders. The company will not receive proceeds from these sales, other than cash from option exercises by management selling stockholders.
Subject to completion of the offering, BrightSpring intends a concurrent stock repurchase of up to the lesser of $50 million or 10% of the offering, with repurchased shares to be cancelled. Shares outstanding were 181,045,317 as of October 17, 2025. Following the offering and the repurchase, shares outstanding would be 179,800,317 assuming a repurchase price of $29.73 and issuance of 255,000 option shares.
Preliminary Q3 2025 results show total revenue of $3,334 million (up 28.2% year over year), gross profit of $392 million (up 21.3%), net income of $37.5 million (vs. a $25.7 million loss), and Adjusted EBITDA $160 million (up 37.2%). As of September 30, 2025, cash and cash equivalents were $140.3 million, total debt was approximately $2.6 billion, and leverage under credit agreements was 3.31x.
BrightSpring Health Services furnished an 8-K announcing it issued a press release with certain preliminary financial information for the third quarter ended September 30, 2025. The press release is provided as Exhibit 99.1.
The disclosure under Item 2.02 is expressly treated as furnished, not filed, under the Exchange Act. The filing also lists Exhibit 104 for the cover page Inline XBRL data.